Cannara Biotech Inc.
LOVE.V
TSX
05/31/2025 | 02/28/2025 | ||||
---|---|---|---|---|---|
Revenue | 4.90% | 1.92% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 4.90% | 1.92% | |||
Cost of Revenue | 0.53% | -5.56% | |||
Gross Profit | 10.30% | 12.99% | |||
SG&A Expenses | 3.49% | -1.56% | |||
Depreciation & Amortization | -19.36% | -3.58% | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 1.10% | -4.46% | |||
Operating Income | 18.57% | 34.24% | |||
Income Before Tax | 24.66% | 49.85% | |||
Income Tax Expenses | 18.72% | 86.81% | |||
Earnings from Continuing Operations | 27.20% | 38.18% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 27.20% | 38.18% | |||
EBIT | 18.57% | 34.24% | |||
EBITDA | 9.87% | 25.51% | |||
EPS Basic | 25.78% | 37.63% | |||
Normalized Basic EPS | 23.14% | 49.67% | |||
EPS Diluted | 10.94% | 37.63% | |||
Normalized Diluted EPS | 23.56% | 49.01% | |||
Average Basic Shares Outstanding | 0.96% | 0.60% | |||
Average Diluted Shares Outstanding | 0.38% | 0.74% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |